ESCEND is registered at clinicaltrials.gov

A Prospective Follow-up Intervention Study: Detection of Early Esophageal Cancer by Near-infrared Fluoresence Molecular Endoscopy Using Bevacizumab-800CW

For detailed information please have a look at clinicaltrials.gov website.